Echopoint Medical

Echopoint Medical is developing a family of optical-fibre-based sensors that integrate into medical innovative devices, bringing unparalleled sensing modalities to minimally-invasive procedures.

The spinout seeks to transform coronary diagnostics by providing a complete picture of coronary physiology with deeper insights into what is happening inside the arteries. This helps clinicians make more informed decisions and tailored treatments that lead to better patient outcomes.

Angiography is the cornerstone of coronary diagnostics at present, but it provides only an anatomical picture of the arteries. Conditions such as microvascular dysfunction, vasospasm, or endothelial disease are invisible on an angiogram, meaning disease can be missed even when patients have significant symptoms.

As a result, patients may be undertreated or undergo unnecessary surgery, and opportunities for tailored, more effective care are missed.

IKor - a tool that measures both large-vessel and microvascular function in real time - could transform how patients are diagnosed and treated, by simplifying complex measurements into a single system.

The Echopoint journey so far:

• 2019: Echopoint founded at UCL 
• 2023: first-in-human trial, demonstrating the potential of iKor™ microcatheter system to transform coronary diagnostics.